Andrew Hollman Meyer - Net Worth and Insider Trading
Andrew Hollman Meyer Net Worth
The estimated net worth of Andrew Hollman Meyer is at least $3 Million dollars as of 2024-12-03. Andrew Hollman Meyer is the Chief Business Officer of Janux Therapeutics Inc and owns about 67,592 shares of Janux Therapeutics Inc (JANX) stock worth over $3 Million. Details can be seen in Andrew Hollman Meyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Hollman Meyer has not made any transactions after 2024-09-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Hollman Meyer
Andrew Hollman Meyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Hollman Meyer owns 1 companies in total, including Janux Therapeutics Inc (JANX) .
Click here to see the complete history of Andrew Hollman Meyer’s form 4 insider trades.
Insider Ownership Summary of Andrew Hollman Meyer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-09-27 | Chief Business Officer |
Andrew Hollman Meyer Latest Holdings Summary
Andrew Hollman Meyer currently owns a total of 1 stock. Andrew Hollman Meyer owns 67,592 shares of Janux Therapeutics Inc (JANX) as of September 27, 2024, with a value of $3 Million.
Latest Holdings of Andrew Hollman Meyer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-09-27 | 67,592 | 40.18 | 2,715,847 |
Holding Weightings of Andrew Hollman Meyer
Andrew Hollman Meyer Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Hollman Meyer has made a total of 1 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Janux Therapeutics Inc is the sale of 50,000 shares on September 27, 2024, which brought Andrew Hollman Meyer around $2 Million.
Insider Trading History of Andrew Hollman Meyer
- 1
Andrew Hollman Meyer Trading Performance
Andrew Hollman Meyer Ownership Network
Andrew Hollman Meyer Owned Company Details
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Andrew Hollman Meyer is the Chief Business Officer of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & Chief Executive Officer David Alan Campbell , director & 10 percent owner Ra Capital Healthcare Fund Lp , and 10 percent owner Avalon Ventures Xi, L.p. .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Andrew Hollman Meyer made 1 insider transaction in Janux Therapeutics Inc (JANX) with a net sale of 50,000. Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 3,324,326 shares made by Avalon Ventures Xi, L.p. , a net sale of 653,961 shares made by Jay Lichter , and a net sale of 75,000 shares made by David Alan Campbell .
In summary, during the past 3 months, insiders sold 2,807,995 shares of Janux Therapeutics Inc (JANX) in total and bought 1,200,000 shares, with a net sale of 1,607,995 shares. During the past 18 months, 6,630,716 shares of Janux Therapeutics Inc (JANX) were sold and 4,244,570 shares were bought by its insiders, resulting in a net sale of 2,386,146 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
Andrew Hollman Meyer Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Hollman Meyer. You might contact Andrew Hollman Meyer via mailing address: C/o Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
